PRN: Thomson Reuters Provides Strategic Insight and Content for Critical National Health and Science Initiatives

12/mar/2012 14.01.21 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Thomson Reuters Provides Strategic Insight and Content for Critical National Health and Science Initiatives

 
[12-March-2012]
 

PHILADELPHIA and LONDON, March 12, 2012 /PRNewswire/ --


- Leading scientific and policy-making organizations around the world rely on citation data and expert consulting services to assess and promote research

The Intellectual Property & Science business of Thomson Reuters announced today it was selected by Alzheimer's Research UK, the Institute of Physics, the National Institutes of Health (NIH), and the National Science Foundation (NSF) to provide essential data and insight into ground-breaking scientific initiatives led by these organizations.

These partnerships will shed new light on the current scientific environments in multiple fields, inform research, and influence policy decision making. Thomson Reuters was selected to provide citation data, unify disparate information sources, and apply insight based on its unique capabilities in evaluating, selecting, and analyzing scientific and scholarly data.

"Thomson Reuters deep understanding of the research process informs each project we undertake, from citation analysis, output measurement and benchmarking to building databases based on our knowledge of how researchers and administrators work and the tools they need to be successful," said Keith MacGregor, executive vice president at Thomson Reuters. "The quality of our data, combined with our extensive analysis tools and trusted expertise, provide policy and decision-support for the important issues facing nations today."

For a current look at the state of the UK's research in Alzheimer's disease and physics, Thomson Reuters performed in-depth bibliometric evaluations to measure and compare performance and provide snapshots of where the UK stands in each field. These analyses were used in Alzheimer's Research UK's Defeating Dementia report and the Institute of Physics' Bibliometric evaluation and international benchmarking of the UK's physics research report, where objective Thomson Reuters data is helping to influence government policies and contribute to wider discussions of research in these fields.

"The work done by Thomson Reuters for the Institute of Physics has helped to provide insights into how the UK can continue to strengthen the quality of its research," said Professor Sir Peter Knight, president of the Institute of Physics. "It is clear from our report that while there are wonderful opportunities for international collaboration, we must be ready to take on challenges to the UK's international reputation for scientific excellence."

Thomson Reuters expertise also helps move research forward. Global Health Connect, a unique online resource for tackling the explosion of Big Data for global health, is under development in partnership with the National Institutes of Health's Office of Technology Transfer and BIO Ventures for Global Health. Once complete, Global Health Connect will support the development of treatments for neglected diseases.

"By bringing disparate databases and research together and suggesting new insights for old problems, this resource will accelerate the development of lifesaving treatments and combat the neglected tropical diseases that afflict the world's poorest people," said Mark Rohrbaugh, Director of the Office of Technology Transfer at NIH.

These recent initiatives are backed by the history of trusted data Thomson Reuters has collected and curated. For forty years, the National Science Foundation has relied on Thomson Reuters citation data to produce its Science and Engineering Indicators, a volume of records comprising the major high-quality, quantitative data on the U.S. and international science and engineering enterprise. Independently-analyzed Thomson Reuters data is also the basis for the report's Academic Research & Development chapter, one of the document's seven major components.

Thomson Reuters partnerships with the NSF, Institute of Physics and Alzheimer's Research UK were backed by Web of Knowledge, the world's leading source of scholarly research and citation data and interpretation by our industry leading subject-matter and research policy experts. The Global Health Connect initiative leverages Thomson Reuters expertise in data management methodology and technology development.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 55,000 people and operates in over 100 countries. Thomson Reuters shares are listed on the Toronto and New York Stock Exchanges. For more information, go to http://www.thomsonreuters.com.


blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl